In insulin-resistant conditions (e.g., type 2 diabetes), patients have altered fatty acid composition, indicating that the insulin pattern can alter the lipid composition in the body [93], and insulin fails to suppress hepatic glucose production but continues to promote lipogenesis, leading to excessive fat accumulation in the liver, a phenomenon known as selective insulin resistance [94]. This evidence concerns the gene INS and type 2 diabetes mellitus.